Skip to main content
PMC home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
editorial
. 1983 Dec 3;287(6406):1651–1652. doi: 10.1136/bmj.287.6406.1651

Antibiotic resistance in Serratia marcescens.

J D Sleigh
PMCID: PMC1550094  PMID: 6416536

Full text

PDF
1653

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexander R. H., Reichenbach D. D., Merendino K. A. Serratia marcescens endocarditis. A review of the literature and report of a case involving a homograft replacement of the aortic valve. Arch Surg. 1969 Mar;98(3):287–291. doi: 10.1001/archsurg.1969.01340090063007. [DOI] [PubMed] [Google Scholar]
  2. Allen S. D., Conger K. B. Serratia marcescens infection of the urinary tract: a nosocomial infection. J Urol. 1969 Apr;101(4):621–623. doi: 10.1016/s0022-5347(17)62391-7. [DOI] [PubMed] [Google Scholar]
  3. Ball A. P., McGhie D., Geddes A. M. Serratia marcescens in a general hospital. Q J Med. 1977 Jan;46(181):63–71. [PubMed] [Google Scholar]
  4. Black W. A., Hodgson R. Search for Serratia. J Clin Pathol. 1971 Jul;24(5):444–448. doi: 10.1136/jcp.24.5.444. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Breed R. S., Breed M. E. The Type Species of the Genus Serratia, Commonly Known as Bacillus Prodigiosus. J Bacteriol. 1924 Nov;9(6):545–557. doi: 10.1128/jb.9.6.545-557.1924. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cook L. N., Davis R. S., Stover B. H. Outbreak of amikacin-resistant Enterobacteriaceae in an intensive care nursery. Pediatrics. 1980 Feb;65(2):264–268. [PubMed] [Google Scholar]
  7. Dodson W. H. Serratia marcescens septicemia. Arch Intern Med. 1968 Feb;121(2):145–150. [PubMed] [Google Scholar]
  8. Ehrenkranz N. J., Bolyard E. A., Wiener M., Cleary T. J. Antibiotic-sensitive Serratia marcescens infections complicating cardiopulmonary operations: contaminated disinfectant as a reservoir. Lancet. 1980 Dec 13;2(8207):1289–1292. doi: 10.1016/s0140-6736(80)92349-1. [DOI] [PubMed] [Google Scholar]
  9. Farmer J. J., 3rd, Davis B. R., Hickman F. W., Presley D. B., Bodey G. P., Negut M., Bobo R. A. Detection of Serratia outbreaks in hospital. Lancet. 1976 Aug 28;2(7983):455–459. doi: 10.1016/s0140-6736(76)92539-3. [DOI] [PubMed] [Google Scholar]
  10. GRABER C. D., HIGGINS L. S., DAVIS J. S. SELDOM-ENCOUNTERED AGENTS OF BACTERIAL MENINGITIS. JAMA. 1965 Jun 14;192:956–960. doi: 10.1001/jama.1965.03080240026005. [DOI] [PubMed] [Google Scholar]
  11. John J. F., Jr, McNeill W. F. Characteristics of Serratia marcescens containing a plasmid coding for gentamicin resistance in nosocomial infections. J Infect Dis. 1981 Jun;143(6):810–817. doi: 10.1093/infdis/143.6.810. [DOI] [PubMed] [Google Scholar]
  12. LANCASTER L. J. Role of Serratia species in urinary tract infections. Arch Intern Med. 1962 May;109:536–539. doi: 10.1001/archinte.1962.03620170034005. [DOI] [PubMed] [Google Scholar]
  13. Langstaff D., Schueler S., Righter J. Netilmicin: in-vitro activity compared with that of other aminoglycosides against Serratia marcescens. J Antimicrob Chemother. 1983 Feb;11(2):187–189. doi: 10.1093/jac/11.2.187. [DOI] [PubMed] [Google Scholar]
  14. Lerner A. M., Reyes M. P., Cone L. A., Blair D. C., Jansen W., Wright G. E., Lorber R. R. Randomised, controlled trial of the comparative efficacy, auditory toxicity, and nephrotoxicity of tobramycin and netilmicin. Lancet. 1983 May 21;1(8334):1123–1126. doi: 10.1016/s0140-6736(83)92864-7. [DOI] [PubMed] [Google Scholar]
  15. Maki D. G., Hennekens C. G., Phillips C. W., Shaw W. V., Bennett J. V. Nosocomial urinary tract infection with Serratia marcescens: an epidemiologic study. J Infect Dis. 1973 Nov;128(5):579–587. doi: 10.1093/infdis/128.5.579. [DOI] [PubMed] [Google Scholar]
  16. McCormack R. C., Kunin C. M. Control of a single source nursery epidemic due to Serratia marcescens. Pediatrics. 1966 May;37(5):750–755. [PubMed] [Google Scholar]
  17. Meltz D. J., Grieco M. H. Characteristics of Serratia marcescens pneumonia. Arch Intern Med. 1973 Sep;132(3):359–364. [PubMed] [Google Scholar]
  18. Michalsen H., Halvorsen K., Bergan T. Netilmicin in the treatment of neonates with moderate and severe infections. Scand J Infect Dis Suppl. 1980;Suppl 23:146–150. [PubMed] [Google Scholar]
  19. Morse L. J., Schonbeck L. E. Hand lotions--a potential nosocomial hazad. N Engl J Med. 1968 Feb 15;278(7):376–378. doi: 10.1056/NEJM196802152780706. [DOI] [PubMed] [Google Scholar]
  20. Phillips I., King A. Serratia marcescens in hospital practice. Lancet. 1977 Mar 5;1(8010):538–538. doi: 10.1016/s0140-6736(77)91392-7. [DOI] [PubMed] [Google Scholar]
  21. Platt D. J., Sommerville J. S., McGroarty J. A. Characterization of spontaneous resistant variants of Serratia marcescens selected in the presence of carbenicillin. J Antimicrob Chemother. 1983 Oct;12(4):329–335. doi: 10.1093/jac/12.4.329. [DOI] [PubMed] [Google Scholar]
  22. Platt D. J., Sommerville J. S. Serratia species isolated from patients in a general hospital. J Hosp Infect. 1981 Dec;2(4):341–348. doi: 10.1016/0195-6701(81)90066-9. [DOI] [PubMed] [Google Scholar]
  23. Rhoades E. R., Ringrose R., Mohr J. A., Brooks L., McKown B. A., Felton F. Contamination of ultrasonic nebulization equipment with gram negative bacteria. Arch Intern Med. 1971 Feb;127(2):228–232. [PubMed] [Google Scholar]
  24. Ringrose R. E., McKown B., Felton F. G., Barclay B. O., Muchmore H. G., Rhoades E. R. A hospital outbreak of Serratia marcescens associated with ultrasonic nebulizers. Ann Intern Med. 1968 Oct;69(4):719–729. doi: 10.7326/0003-4819-69-4-719. [DOI] [PubMed] [Google Scholar]
  25. Sanders C. V., Jr, Luby J. P., Johanson W. G., Jr, Barnett J. A., Sanford J. P. Serratia marcescens infections from inhalation therapy medications: nosocomial outbreak. Ann Intern Med. 1970 Jul;73(1):15–21. doi: 10.7326/0003-4819-73-1-15. [DOI] [PubMed] [Google Scholar]
  26. Schaberg D. R., Alford R. H., Anderson R., Farmer J. J., 3rd, Melly M. A., Schaffner W. An outbreak of nosocomial infection due to multiply resistant Serratia marcescens: evidence of interhospital spread. J Infect Dis. 1976 Aug;134(2):181–188. doi: 10.1093/infdis/134.2.181. [DOI] [PubMed] [Google Scholar]
  27. Shannon K., Phillips I. Mechanisms of resistance to aminoglycosides in clinical isolates. J Antimicrob Chemother. 1982 Feb;9(2):91–102. doi: 10.1093/jac/9.2.91. [DOI] [PubMed] [Google Scholar]
  28. Stamm W. E., Kolff C. A., Dones E. M., Javariz R., Anderson R. L., Farmer J. J., 3rd, de Quinones H. R. A nursery outbreak caused by Serratia marcescens--scalp-vein needles as a portal of entry. J Pediatr. 1976 Jul;89(1):96–99. doi: 10.1016/s0022-3476(76)80940-7. [DOI] [PubMed] [Google Scholar]
  29. Tabaqchali S., Chambers T. J., Brooks H. J. Serratia marcescens in hospital practice. Lancet. 1977 Feb 5;1(8006):306–307. doi: 10.1016/s0140-6736(77)91851-7. [DOI] [PubMed] [Google Scholar]
  30. Wersäll J. The ototoxic potential of netilmicin compared with amikacin. An animal study in guinea pigs. Scand J Infect Dis Suppl. 1980;Suppl 23:104–113. [PubMed] [Google Scholar]
  31. Whitby J. L., Blair J. N., Rampling A. Cross-infection with Serratia marcescens in an intensive-therapy unit. Lancet. 1972 Jul 15;2(7768):127–129. doi: 10.1016/s0140-6736(72)91612-1. [DOI] [PubMed] [Google Scholar]
  32. Yu V. L., Oakes C. A., Axnick K. J., Merigan T. C. Patient factors contributing to the emergence of gentamicin-resistant Serratia marcescens. Am J Med. 1979 Mar;66(3):468–472. doi: 10.1016/0002-9343(79)91074-x. [DOI] [PubMed] [Google Scholar]
  33. Yu V. L. Serratia marcescens: historical perspective and clinical review. N Engl J Med. 1979 Apr 19;300(16):887–893. doi: 10.1056/NEJM197904193001604. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES